Similar articles

• HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. Clin Exp Immun 1994;98:178-84.

  DePalma L. DePalma L. Pediatr AIDS HIV Infect. 1995 Apr;6(2):97-8. Pediatr AIDS HIV Infect. 1995. PMID: 11361387 No abstract available.
• Vaccination with gp160 in HIV.

  Oyaizu N, Chirmule N, Pahwa S. Oyaizu N, et al. N Engl J Med. 1992 Jan 30;326(5):347; author reply 348. N Engl J Med. 1992. PMID: 1728747 Clinical Trial. No abstract available.
• AIDS vaccine boosts immunity in HIV patients.

  [No authors listed] [No authors listed] RN. 1991 Oct;54(10):103. RN. 1991. PMID: 1925340 No abstract available.
• Human trials of AIDS vaccines: current status and future directions.

  Koff WC, Fauci AS. Koff WC, et al. AIDS. 1989;3 Suppl 1:S125-9. AIDS. 1989. PMID: 2558684 Review. No abstract available.
• Humoral immunity to HIV, SIV, and SHIV.

  Haigwood NL, Zolla-Pazner S. Haigwood NL, et al. AIDS. 1998;12 Suppl A:S121-32. AIDS. 1998. PMID: 9632993 Review. No abstract available.